Perifosine (NSC-639966)
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
Discription | Perifosine (also KRX-0401) acts as an Akt inhibitor and a PI3K inhibitor. | ||
---|---|---|---|
Targets |
|
Catalog Num | A10709 |
---|---|
Formula | C25H52NO4P |
Molecular Weight | 461.7 |
CAS Number | 157716-52-4 |
SMILES | CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](CC1)(C)C |
Synonyms | KRX-0401 |
Storage | Store lyophilized at -20ºC, keep desiccated. |
In vitro (25°C) | DMSO | Insoluble | |
Water | 85 mg/mL (184.11mM) | ||
Ethanol | 85 mg/mL (184.11mM) | ||
In vivo | water | 7 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.66 mL | 108.3 mL | 216.59 mL |
0.5 mM | 4.33 mL | 21.66 mL | 43.32 mL |
1 mM | 2.17 mL | 10.83 mL | 21.66 mL |
5 mM | 0.43 mL | 2.17 mL | 4.33 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2